| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/09/2011 | US20110136789 C-met protein kinase inhibitors |
| 06/09/2011 | US20110136780 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
| 06/09/2011 | US20110136778 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof |
| 06/09/2011 | US20110136767 Processes for preparing piperazinium salts of kmup and use thereof |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136744 Cyclosporin analog formulations |
| 06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
| 06/09/2011 | US20110135691 Immunomodulation by iap inhibitors |
| 06/09/2011 | US20110135688 Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors |
| 06/09/2011 | US20110135686 Replication-Defective Flavivirus Vaccines and Vaccine Vectors |
| 06/09/2011 | US20110135684 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro |
| 06/09/2011 | US20110135682 Recombinant Bicistronic Flaviviruses and Methods of Use Thereof |
| 06/09/2011 | US20110135680 Deletion mutants of flagellin and methods of use |
| 06/09/2011 | US20110135679 Compositions for inducing immune responses |
| 06/09/2011 | US20110135678 Tolerizing agents |
| 06/09/2011 | US20110135677 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 06/09/2011 | US20110135676 Novel antiviral peptide against avian influenza virus h9n2 |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135672 Hla-g compositions and methods of use thereof |
| 06/09/2011 | US20110135671 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135670 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135669 Synthetic agonists of tlr9 |
| 06/09/2011 | US20110135666 Regulatory b cells and their uses |
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135645 Human antibodies neutralizing human metapneumovirus |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135624 Therapeutic composition for autoimmune conditions |
| 06/09/2011 | US20110135603 Inhibitors of phosphatidylinositol 3-kinase |
| 06/09/2011 | US20110135602 Supperssor of the endogenous interferon-gamma |
| 06/09/2011 | US20110135598 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
| 06/09/2011 | US20110135581 Methods and Compositions for Reducing Lung Inflammation in an Animal |
| 06/09/2011 | US20110135573 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | CA2782406A1 Atoxic recombinant holotoxins of clostridium difficile as immunogens |
| 06/08/2011 | EP2330219A2 Method for drug discovery, disease treatment and diagnosis using metabolomics |
| 06/08/2011 | EP2330212A1 Novel compound ceramidastin, process for production thereof, and use thereof |
| 06/08/2011 | EP2330187A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseases |
| 06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2328896A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 06/08/2011 | EP1485127B1 Administration of agents for the treatment of inflammation |
| 06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
| 06/08/2011 | EP1431293B1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1259259B1 Mucosal adjuvant formulation |
| 06/08/2011 | EP1078093B1 Vaccines, immunotherapeutics and methods for using the same |
| 06/08/2011 | CN1816544B Immunosuppressant compounds and compositions |
| 06/08/2011 | CN1700918B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102089005A Staphylococcus aureus-specific antibody preparations |
| 06/08/2011 | CN102089001A Immunity-inducing agent and method for detection of cancer |
| 06/08/2011 | CN102088996A Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory T-cells |
| 06/08/2011 | CN102088872A Sialic acid to support the immune system in the elderly |
| 06/08/2011 | CN102086459A Fusion protein immunosuppressive agent and preparation method and application thereof |
| 06/08/2011 | CN102086237A Method for preparing jujube polysaccharide from red dates and jujube polysaccharide |
| 06/08/2011 | CN102086236A Method for extracting and separating in vivo alkali-soluble polysaccharide from old water shield leaves |
| 06/08/2011 | CN102086226A Method for preparing cyclosporine A |
| 06/08/2011 | CN102086195A Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 06/08/2011 | CN102086182A Petasites tatewakianus Kitam. extract as well as preparation method and application thereof |
| 06/08/2011 | CN102085368A Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating systemic lupus erythematosus |
| 06/08/2011 | CN102085365A Application of thymopentin in intranasal vaccine |
| 06/08/2011 | CN102085364A Application of thymopentin in emulsion type injection vaccine |
| 06/08/2011 | CN102085308A Traditional Chinese medicine prescription for treating skin allergy |
| 06/08/2011 | CN102085294A Medicinal composition with immunoregulation effect |
| 06/08/2011 | CN102085256A Immune regulation oral liquid preparation with anti-cancer efficacy and preparation method of a main component thereof |
| 06/08/2011 | CN102085242A Common fig health-care capsules |
| 06/08/2011 | CN102085235A Composition having immunity-enhancing effect |
| 06/08/2011 | CN102085218A Injection for treating skin allergy and allergic asthma and preparation method thereof |
| 06/08/2011 | CN102085028A Medicinal health protection shoe pad |
| 06/08/2011 | CN102085027A Medical health care insoles |
| 06/08/2011 | CN101780138B Product for enhancing body immunity and capable of resisting fatigue and preparation method thereof |
| 06/08/2011 | CN101632642B Taste and stability improved formula |
| 06/08/2011 | CN101623502B Preparation method of Ganodenic acid monomer Me cyclodextrin inclusion compound and of oral solid preparation |
| 06/08/2011 | CN101612119B Cucurbitacin solid lipid nanoparticle preparation and preparation method thereof |
| 06/08/2011 | CN101585823B New immunosuppressive agent extracted from Honghuoma and extraction method and use thereof |
| 06/08/2011 | CN101569690B Preparation method for compound plant polypeptide |
| 06/08/2011 | CN101480432B Compound Chinese herbal medicine immunopotentiator for Rachycentron canadum |
| 06/08/2011 | CN101439080B Chinese medicinal composition for improving immunity of organism |
| 06/08/2011 | CN101406486B Method for preparing maggot health-care oral liquid |
| 06/08/2011 | CN101209258B Immunopotentiator and antiviral composition for animal |
| 06/08/2011 | CN101209085B Feed capable of reducing body fat and mortality rate of chicken and breeding method therewith |
| 06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
| 06/07/2011 | US7956187 Method for decreasing opioid metabolism |
| 06/07/2011 | US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 06/07/2011 | US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/07/2011 | US7955833 Derived from soy hydrolysate and yeast hydrolysate; useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal proteins |
| 06/07/2011 | US7955626 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 06/07/2011 | US7955607 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 06/07/2011 | US7955597 Anti-IL-6 antibodies, compositions, methods and uses |
| 06/07/2011 | US7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 06/07/2011 | CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |